Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed

References

• Girolami A, Scarano L, Saggiorato G, et al. Congenital deficiencies and abnormalities of prothrombin. Blood Coagul Fibrinolysis. 1998;9:557–569. doi: 10.1097/00001721-199810000-00001
   PubMed Web of Science ®Google Scholar
• Lancellotti S, De Cristofaro R. Congenital prothrombin deficiency. Semin Thromb Hemost. 2009;35:367–381. doi: 10.1055/s-0029-1225759
   PubMed Web of Science ®Google Scholar
• Lancellotti S, Basso M, De Cristofaro R. Congenital prothrombin deficiency: an update. Semin Thromb Hemost. 2013;39:596–606. doi: 10.1055/s-0033-1348948
   PubMed Web of Science ®Google Scholar
• Lefkowitz JB, Weller A, Nuss R, et al. A common mutation, Arg457-->Gln, links prothrombin deficiencies in the Puerto Rican population. J Thromb Haemost. 2003;1:2381–2388. doi: 10.1046/j.1538-7836.2003.00420.x
   PubMed Web of Science ®Google Scholar
• Girolami A, Scandellari R, Scapin M, et al. Congenital bleeding disorders of the vitamin K-dependent clotting factors. Vitam Horm. 2008;78:281–374. doi: 10.1016/S0083-6729(07)00014-3
   PubMed Web of Science ®Google Scholar
• Miyawaki Y, Suzuki A, Fujita J, et al. Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med. 2012;366:2390–2396. doi: 10.1056/NEJMoa1201994
   PubMed Web of Science ®Google Scholar
• Sivasundar S, Oommen AT, Prakash O, et al. Molecular defect of ‘Prothrombin Amrita’: substitution of arginine by glutamine (Arg553 to Gln) near the Na(+) binding loop of prothrombin. Blood Cells Mol Dis. 2013;50:182–183. doi: 10.1016/j.bcmd.2012.11.008
   PubMed Web of Science ®Google Scholar
• Djordjevic V, Kovac M, Miljic P, et al. A novel prothrombin mutation in two families with prominent thrombophilia – the first cases of antithrombin resistance in a Caucasian population. J Thromb Haemost. 2013;11:1936–1939.
   PubMed Web of Science ®Google Scholar
• Kishimoto M, Suzuki N, Murata M, et al. The first case of antithrombin-resistant prothrombin Belgrade mutation in Japanese. Ann Hematol. 2016;95:541–542. doi: 10.1007/s00277-015-2533-6
   PubMed Web of Science ®Google Scholar
• Bulato C, Radu CM, Campello E, et al. New prothrombin mutation (Arg596Trp, prothrombin Padua 2) associated with venous thromboembolism significance. Arterioscler Thromb Vasc Biol. 2016;36:1022–1029. doi: 10.1161/ATVBAHA.115.306914
   PubMed Web of Science ®Google Scholar
• Akhavan S, De Cristofaro R, Peyvandi F, et al. Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype. Blood. 2002;100:1347–1353. doi: 10.1182/blood-2002-01-0243
   PubMed Web of Science ®Google Scholar
• Henriksen RA, Dunham CK, Miller LD, et al. Prothrombin Greenville, Arg517→Gln, identified in an individual heterozygous for dysprothrombinemia. Blood. 1998;91:2026–2031.
   PubMed Web of Science ®Google Scholar
• Henriksen RA, Owen WG, Nesheim ME, et al. Identification of a congenital dysthrombin, thrombin quick. J Clin Invest. 1980;66:934–940. doi: 10.1172/JCI109961
   PubMed Web of Science ®Google Scholar
• Miyata T, Aruya R, Umeyama H, et al. Prothrombin Salakta: substitution of glutamic acid 466 by alanina residues the fibrinogen clotting activity and the esterase activity. Biochem. 1992;31:7457–7462. doi: 10.1021/bi00148a005
   PubMed Web of Science ®Google Scholar
• Sun WY, Smirnow D, Jenkins ML, et al. Prothrombin Scranton: substitution of an amino acid residue involved in the binding of Na+ (LYS-556 to THR) leads to dysprothrombinemia. Thromb Haemost. 2001;85:651–654.
   PubMed Web of Science ®Google Scholar
• Sekine O, Sugo T, Ebisawa K, et al. Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activity. Thromb Haemost. 2002;87:282–287.
   PubMed Web of Science ®Google Scholar
• Stanchev H, Philips M, Villoutreix BO, et al. Prothrombin deficiency caused by compound heterozygosity for two novel mutations in the prothrombin gene associated with a bleeding tendency. Thromb Haemost. 2006;95:195–198.
   PubMed Web of Science ®Google Scholar
• Ding Q, Yang L, Zhao X, et al. Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation. Thromb Haemost. 2017;117:479–490. doi: 10.1160/TH16-10-0750
   PubMed Web of Science ®Google Scholar
• Lusher JH. Thrombogenicity associated with factor IX complex concentrates. Semin Hematol. 1991;28:3–5.
   PubMed Web of Science ®Google Scholar
• Girolami A, Tezza F, Scandellari R, et al. Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. critical review of the literature. J Thromb Thrombolysis. 2010;30:172–178. doi: 10.1007/s11239-009-0435-y
   PubMed Web of Science ®Google Scholar
• Girolami A, Ruzzon E, Fabris F, et al. Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol. 2006;116:120–125. doi: 10.1159/000093642
   PubMed Web of Science ®Google Scholar
• Girolami A, Cosi E, Tasinato V, et al. Pulmonary embolism in congenital bleeding disorders: intriguing discrepancies among different clotting factors deficiencies. Blood Coagul Fibrinolysis. 2016;27:517–525. doi: 10.1097/MBC.0000000000000437
   PubMed Web of Science ®Google Scholar
• Girolami A, Bertozzi I, Rigoni I, et al. Congenital FVII deficiency and thrombotic events after replacement therapy. J Thromb Thrombolysis. 2011;32:362–367. doi: 10.1007/s11239-011-0603-8
   PubMed Web of Science ®Google Scholar
• Poort SR, Njo KT, Vos HL, et al. Two novel mutations in the prothrombin gene cause severe bleeding in a compound heterozygous patient. Blood Coagul Fibrinolysis. 1998;9:761–764. doi: 10.1097/00001721-199811000-00007
   PubMed Web of Science ®Google Scholar
• Akhavan S, Mannucci PM, Lak M, et al. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency. Thromb Haemost. 2000;84:989–997.
   PubMed Web of Science ®Google Scholar
• O’Marcaigh AS, Nichols WL, Hassinger NL, et al. Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia. Blood. 1996;88:2611–2618.
   PubMed Web of Science ®Google Scholar
• Girolami A, Candeo N, Vettore S, et al. The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency. J Thromb Thrombolysis. 2010;29:299–302. doi: 10.1007/s11239-009-0342-2
   PubMed Web of Science ®Google Scholar
• Simioni P, Tormene D, Tognin G, et al. X-linked thrombophilia with a mutant factor IX (factor IX Padua). N Engl J Med. 2009;361:1671–1675. doi: 10.1056/NEJMoa0904377
   PubMed Web of Science ®Google Scholar
• De Moraes Mazetto B, Orsi FL, Siqueira LH, et al. Prevalence of factor IX-R338L (factor IX Padua) in a cohort of patients with venous thromboembolism and mild elevation of factor IX levels. Thromb Res. 2010;126:e165. doi: 10.1016/j.thromres.2010.04.019
   PubMed Web of Science ®Google Scholar
• Koenderman JS, Bertina RM, Reitsma PH, et al. Factor IX-R338L (factor IX Padua) screening in a Dutch population of sibpairs with early onset venous thromboembolism. Thromb Res. 2011;128:603. doi: 10.1016/j.thromres.2011.07.009
   PubMed Web of Science ®Google Scholar
• Monahan PE, Sun J, Gui T, et al. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial. Hum Gene Ther. 2015;26:69–81. doi: 10.1089/hum.2014.106
   PubMed Web of Science ®Google Scholar
• Cantore A, Nair N, Della Valle P, et al. Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice. Blood. 2012;120(23):4517–4520. doi: 10.1182/blood-2012-05-432591
   PubMed Web of Science ®Google Scholar